Tanking Stock

Quote












Internal rumor is the top three companies that are looking to buy $RVNC is Kodak, Blockbuster and Toys r Us. At Revance’s rate of decline in valuation, those three companies will have enough money to buy Revance in a 2-3 days tops! It’s a POS, stay far away.
 








































This is a crime. Employees encouraged to buy stock at a discount and offering lame performance shares that are now worthless because of his mismanagement. Dustin as President was a poor decision, VP of sales a poor decision and everyone on the Daxxify Marketing team. The stock is worthless. How do you lose 90% capital. Horrible management. Many lost remarkable amounts of money. How anyone can still work for this man is astonishing. He has failed yet has no issue with taking this salary. Shameful.

Revance Therapeutics' CEO is Mark Foley, appointed in Oct 2019, has a tenure of 4.42 years. total yearly compensation is $10.07M, comprised of 7.2% salary and 92.8% bonuses, including company stock and options. directly owns 1.06% of the company's shares, worth $5.44M



anonymous said:
Q3 earnings call Nov 8. What else will go wrong!
Click to expand...
 




























Top Bottom
Back
Quote